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Abstract
With the availability of genomic sequence from numerous vertebrates, a paradigm shift
has occurred in the identification of distant-acting gene regulatory elements.  In contrast
to traditional gene-centric studies in which investigators randomly scanned genomic
fragments that flank genes of interest in functional assays, the modern approach begins
electronically with publicly available comparative sequence datasets that provide
investigators with prioritized lists of putative functional sequences based on their
evolutionary conservation.  However, although a large number of tools and resources are
now available, application of comparative genomic approaches remains far from trivial.
In particular, it requires users to dynamically consider the species and methods for
comparison depending on the specific biological question under investigation.  While
there is currently no single general rule to this end, it is clear that when applied
appropriately, comparative genomic approaches exponentially increase our power in
generating biological hypotheses for subsequent experimental testing.
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1.  Introduction
One of the most intriguing features of biology is the identical DNA content across all
cells within an organism and yet the ability of this genetic information to dictate the
enormous cellular diversity within the body.  Rather, cell type complexity arises
predominantly from vast temporal and spatial differences in gene expression during
development.  The principal mechanism underlying this gene expression diversity across
cell types is dynamic gene regulation induced by a variety of interacting transcription
factors which are also encoded by our genome and subject to tight regulation [1-3].
Transcription factors recognize specific target sequences located within gene promoters
and/or more distant acting cis-regulatory regions, and function to either enhance or
repress a given gene’s cellular expression.  Through this highly orchestrated process,
higher organisms have been able to evolve beyond the limitations of unicellularity to
create complex forms and functions.
Insights into this complexity are beginning to emerge for the human genome with the
availability of a complete genomic sequence template [4,5].  This starting point has led to
the identification of the ~25,000 genes in the human genome, albeit work remains to be
done in deciphering all of their functions.  Gene identification was greatly facilitated by
having access to protein sequence databases and “expressed sequence tags” where
computational algorithms for gene identification could subsequently be built based upon
knowledge gained from these experimental datasets.  In contrast, the availability of the
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human genome sequence alone provided no additional clues as to the precise locations of
distant-acting gene enhancers.  Challenges included the large noncoding search space in
the human genome (~98% of 3x109 bp), the small size and degenerate nature of
transcription factor binding sites, and most importantly the lack of experimental training
sets for computational methods to identify such sequences in a global manner.  The
recent determination of additional genome sequences from other vertebrates has proven
to be powerful at identifying the location of candidate distant-acting cis-regulatory
elements based on their evolutionary conservation across appropriately distanced species.
In this review, we describe the use of comparative genomics as an increasingly powerful
strategy for sequence-based enhancer identification.  In particular, we provide an
overview of selected computational tools and resources that are useful for the
identification of enhancers involved in development and/or specific gene function.  We
end by highlighting the challenges arising from the identification of large numbers of
putative enhancers through comparative genomics and the need to develop high
throughput functional assays to determine their spatiotemporal in vivo activity at a
genomic scale.
2.  Role of Noncoding Sequences in Development and Human Disease
Traditionally, most studies of the genetic networks underlying vertebrate development
have focused on the proteins that are involved, since they are – compared to regulatory
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sequences – generally easier to identify and more readily accessible to a variety of
experimental methods.  However, these proteins are generally limited to functional
activity only in tissues where they are expressed, thereby stressing the importance of
understanding the intricacies of gene regulation to comprehend regulatory networks in
their entirety.  In this section, we provide a brief overview of insights gained from gene-
centric in-depth studies.  While the list of examples described here is by no means
exhaustive, it illustrates some of the major properties and characteristics of distant-acting
cis-regulatory elements and exemplifies their important role in vertebrate development
and human disease.
2.1  Modularity of Transcriptional Regulation by Enhancers
A characteristic feature of enhancers is the modular mode by which they regulate gene
expression.  One of many insightful examples for these properties can be obtained by
examination of the human apolipoprotein E (APOE) locus.  At least six distinct sequence
elements flanking this gene control different aspects of APOE expression.  Namely, the
enhancement of kidney expression has been ascribed to the promoter [6], while elements
located downstream of the gene include two liver-specific enhancers [7,8], a skin
enhancer [6,9], two multiple tissue enhancers directing gene expression to adipocytes,
macrophages and brain astrocytes [9,10], and a distal brain-specific enhancer [11].  It is
worth noting that each of these discrete elements are on the order of several hundred
basepairs in length and are scattered across 42 kilobases.  A second example where the
modularity of transcriptional regulation has been experimentally studied in great detail is
the cardiac homeobox gene Nkx2-5 (Csx).  This gene is required for heart development
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[12] and series of deletions and transgenic reporter experiments were used to dissect both
its proximal and distal regulatory regions [13-18].  These studies revealed that at least
five distinct elements target Nkx2-5 gene expression to specific sub-regions of the
developing heart as well as to non-cardiac tissues and it has been suggested that this
regulatory complexity played a important role in the evolution of the multi-chambered
mammalian heart [19].  Thus, modular transcriptional regulation appears to be a common
mechanism of complex gene regulation and a number of gene-centric studies beyond the
selected examples of APOE and Nkx2-5 have further supported the concept that the
complex expression patterns of genes across tissues regularly arise from the combined
activity of multiple elements.
2.2  Spatiotemporal Precision of Developmental Enhancers
Another remarkable feature of enhancers is the high spatiotemporal precision with which
they regulate gene expression.  One example of the tight restriction of the timing and
tissue-specificity of enhancer activity during embryonic development is the Hoxd11
locus.  Deletion of a single Hoxd11 regulatory element in mice delays expression of both
Hoxd10 and Hoxd11 during somitogenesis, but at later stages normal expression of
Hoxd10 and Hoxd11 is restored [20].  It is hypothesized that this partial gene expression
rescue is mediated by complementary regulatory elements present in this region.  Since
only a subset of anatomical regions lack Hoxd11 expression temporally, this gene
regulatory deletion results in vertebral patterning and specification defects but of lesser
severity than complete Hoxd11 gene knockouts.
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The Hoxd11 locus thus demonstrates how a single enhancer regulates a relatively subtle,
yet functionally important spatiotemporal sub-aspect of the expression pattern of a key
developmental gene.  The general picture emerging from this and other similar gene-
centric studies is that the high spatiotemporal precision of single enhancers – in
combination with their modular mode of action – has allowed complex gene expression
patterns to evolve.  This is particularly the case for many developmentally important
genes, whose expression patterns appear to be frequently the result of the orchestrated
activity of several different enhancers with distinct spatiotemporal activity patterns.
Importantly, these single elements tend to be more restricted in their tissue specificity
than the mRNA expression patterns to which they contribute, providing researchers with
reagents for tissue-specific targeting of gene expression.
2.3  Enhancers are Required for Vertebrate Development
Like mutations in the protein-coding portion of genes, deletions or mutations of
regulatory elements can result in developmental defects, such as in the Hoxd11 locus (see
section 2.2).  Another example from the Hox gene family is the 200bp “early enhancer”
(EE) of the Hoxc8 gene.  Deletion of this enhancer results in delayed expression of the
Hoxc8 protein and in skeletal defects that recapitulate aspects of the Hoxc8-/- phenotype
[21], demonstrating that this regulatory element is required for normal embryogenesis.
As a third example, deletion of three brain-specific enhancers of Otx2 [22,23] revealed
that they are required for maintaining normal expression levels of Otx2 in the developing
brain.  While deletion of these enhancers did not result in obvious phenotypes, compound
heterozygous embryos in which one Otx2 allele was null and the other allele was an Otx2
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enhancer deletion displayed defects in brain development.  These results support that
while each of these elements is not absolutely required for viability, they play an
important role in embryonic development through their coordinated and quantitative
effects on gene expression.
Of note, defects resulting from deletion or mutation of regulatory elements are usually
restricted to the tissue in which they drive expression.  This property can be exploited to
study gene functions that are otherwise difficult to assess experimentally.  For example,
the role of Hand2 in craniofacial development cannot be studied by targeted deletion of
the gene itself because Hand2-/- embryos die from cardiac abnormalities before the
differentiation of craniofacial features.  However, deletion of a branchial arch-specific
Hand2 enhancer in mice results in craniofacial defects including cleft palate and
mandibular hypoplasia, demonstrating a role both for this enhancer and the Hand2 gene
in craniofacial development [24].  These studies allowed for the dissection of the
regulatory architecture of this locus through the separate assessment of the roles of this
gene in cardiac and craniofacial development.  Another important possibility arising from
the identification of tissue-specific enhancers is the possibility to use them to drive the
expression of Cre recombinase.  Such constructs can be used to generate tissue-specific
knockouts by introducing flanking LoxP sites to the gene of interest [25].  For example,
the conditional Cre/Lox-mediated deletion of Mef2c using a myocardial-specific
enhancer has been used to examine the role of Mef2c beyond developmental stages at
which mice with a complete deletion of Mef2c die from cardiovascular defects [26].
Thus, even in cases where the deletion of an enhancer is insufficient to abolish gene
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expression in a particular tissue, the enhancer can be used to study the function of the
respective gene in a tissue-specific manner.
Indeed, many enhancers do not cause an overt phenotype beyond changes in expression
levels of the target gene when experimentally deleted in mice.  Examples include tissue-
or cell type-specific enhancers for Engrailed2 [27], Fgf4 [28], Gata1 [29] or MyoD [30].
An obvious explanation for the frequent absence of phenotypes in enhancer deletion
experiments is that often only one aspect of a complex endogenous mRNA expression
pattern is affected, while expression of the gene in other tissues or at other stages is
maintained.  This higher spatiotemporal restriction is therefore expected to result in
generally milder effects than deletion of entire genes.  A second explanation is functional
redundancy, which might be more common among regulatory elements than it is among
protein-coding genes.  While being sufficient to drive expression in reporter assays, many
enhancers could be dispensable for normal development and physiology because their
function is complemented by other regulatory elements with similar tissue specificity.
Such redundancy of regulatory elements has, for instance, been directly shown for the
TCR-gamma locus, where a deletion of two enhancers results in severe reduction in
gamma-delta-thymocytes, whereas single deletion of either element did not cause a major
immunological phenotype [31].  Functional redundancy does not imply that these
enhancers are functionally less important and that their deletion does not reduce
reproductive fitness.  Rather it indicates that many enhancers are involved in fine-tuning
gene expression.  These findings also raise the possibility that functional redundancies
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are a factor in the comparative studies described below, since they might result in
reduced evolutionary conservation of such elements.
2.4  Enhancers Contribute to Human Disease
As a result of our limited knowledge about the location of most enhancers in the genome,
the contribution of distant acting mutations to human disease has so far not been explored
on a large scale.  One of the few known examples is the limb-specific ZRS long-distance
enhancer of Sonic hedgehog (SHH).  This element is located at the extreme distance of
one megabase from the gene it regulates, residing in the intron of a neighboring gene.
Genetic lesions affecting this element cause polydactyly both in human individuals and in
mutant mouse strains, demonstrating the crucial role of enhancers during mammalian
development [32].  Elimination of the conserved intronic region in which this enhancer is
embedded results in severe limb truncations in mice, strongly supporting human disease
studies [33].  Even point mutations in this regulatory element cause human preaxial
polydactyly [34], offering an explanation why many enhancers are highly constrained and
therefore often conserved across long evolutionary distances.  While hundreds of
regulatory mutations contributing to human disease have been reported [35], most of
them affect promoter regions whose precise location is known for many human genes.  It
is expected that with growing numbers of identified human enhancers it will become
possible to target systematic screens increasingly for regulatory mutations in this distant-
acting class of gene regulatory elements.
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2.5  Challenges
The selected examples above highlight the important role of enhancers in development
and disease.  However, it must be emphasized that the vast majority of distant-acting
regulatory sequences in the mammalian genome has so far not been experimentally
characterized either in vitro or in vivo and their overall contribution to human disease
remains unclear.  Two major challenges have rendered large-scale studies of
developmental enhancers difficult.  First, the absence of suitable prediction methods
continues to present a major obstacle for identifying the location of these elements,
especially for those that act over long distances.  Second, the limited number of known
developmental enhancers has largely prevented prediction by computational analysis
because no suitable training sets of enhancers characterized by standardized experimental
methods have been available.  In consequence, our understanding of the sequence
features involved in enhancer function remains limited to gene-centric studies and single
elements.  In the next sections, we will describe recent efforts to tackle both of these
problems.  Namely, recently developed methods and computational tools for comparative
genomics have significantly improved our ability to identify the location of putative
enhancers in the human genome and provide a starting point for large-scale experimental
characterization of enhancers.
3.  Enhancer Identification by Comparative Genomic Strategies
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Cross-species sequence comparisons were shown to be an efficient approach to identify
putative functional regions in noncoding DNA even before whole genome sequences of
humans and other vertebrates became available.  Many variations on this theme have
been presented, including variation of the species being compared and different
comparison methods, yet they all rely on the same basic principle: that functionally
relevant sequences are under negative selection, whereas non-functional regions are
subject to genetic drift and become increasingly different between species with increasing
phylogenetic distance.  As a result, functional sequences generally stand out as more
“conserved” than non-functional sequences when genomic sequences of different species
are compared.  Sequence conservation between different species can thus be used to
identify putative functional regions, and many of these will be cis-regulatory elements.
3.1  Pre-Genome-Scale Comparative Approaches
Bottom-up approaches provided the early foundation for the utility of cross-species
comparisons for the identification of cis-regulatory elements in the genomic sequence of
a gene of interest (for early examples, see references 36,37).  In the absence of publicly
available whole-genome sequence data and specialized computational tools for these
purposes, this strategy usually included cloning and sequencing of orthologous
noncoding sequences from two or more organisms, manual alignment and identification
of conserved regions at the nucleotide level, often focusing on transcription factor
binding sites.  In reference to experimentally exploring these sequences through DNase
footprinting, such approaches became known as “phylogenetic footprinting”.
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Such gene-centric studies provided an important proof of principle, but the hypothesis
that sequence conservation is a universal predictor of noncoding regulatory sequences
was difficult to verify conclusively in the absence of sequence data for genome-wide
comparisons.  Thus, the prospect of genome-wide comparative identification of cis-
regulatory regions was early recognized as an important motivation to sequence the
genomes of the mouse and other vertebrates in addition to the human genome [38,39].
3.2 Using Genomic Data in Comparative Approaches
Even before sufficient sequence data for whole-genome comparisons became available,
the merits of comparative approaches for enhancer identification were confirmed in
studies that involved the sequencing of large genomic intervals.  For example, Göttgens
et al. [40] sequenced a 320kb interval of the stem cell leukemia (SCL) locus in human,
mouse and chicken to identify regulatory candidate regions.  A subset of these regions
corresponded to known regulatory elements and functional testing of previously
uncharacterized conservation peaks led to the discovery of a new neural enhancer in the
SCL locus.  In another study, Loots et al. [41] identified multiple noncoding elements
regulating the human interleukin-4, -5, and -13 genes by sequencing and aligning one
megabase of human chromosome 5 and the orthologous mouse genome region.  These
results lent further support to the notion that conservation of noncoding sequences can be
used to predict functional regions including regulatory elements in genomic sequence
data.
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The publication of the mouse and the pufferfish genomes in 2002 marked the kick-off for
genome-wide comparative approaches since they allowed for the first time systematic
large-scale comparisons of the human with non-human vertebrate genomes [42,43].
Comparative analysis of the human and mouse genomes was particularly productive
because their size is similar, 90% of these genomes are organized in syntenic blocks in
which the respective order of genes is maintained, and in an initial analysis 40% of the
two genomes were found to be alignable at the nucleotide level.  Interestingly, while only
~1.5% of the human and mouse genome encode proteins, ~5% of these mammalian
genomes were estimated to be under purifying selection, suggesting that much more than
protein encoding functions are constrained within our genome [43].  However, a
multitude of functions can potentially be embedded into non-protein-coding DNA,
including activating and repressing regulatory binding sites, known and unknown
functional RNA types, and structural chromatin features.  Most of these cannot be
reliably predicted by existing computational methods, therefore the functional relevance
of constrained noncoding regions remained initially obscure.
Subsequent functional testing of such conserved regions revealed, however, that one of
the predominant functions of constrained noncoding DNA seems in fact to be the tissue-
specific spatial and temporal regulation of gene expression.  One of the likely reasons for
this is the large size of many enhancer sequences, conserved over hundreds of basepairs,
which makes it possible to identify them through whole genome comparisons.  In what
follows, we provide an overview of comparative strategies that have so far been
successfully used to find such cis-regulatory elements (for a more detailed discussion of
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general considerations regarding comparisons over different evolutionary distances,
including the advantages and limitations of distant and close comparisons, see reference
44).
3.2.1 Deep Comparisons: Human-Fish
In the pre-genomic era, studies focusing on single genes suggested that distant
evolutionary comparison could be useful to identify regulatory regions involved in core
aspects of vertebrate development.  For example over 10 years ago, Aparicio et al. [45]
used comparisons between mouse and pufferfish (Fugu rubripes) to identify functional
regulatory elements in the Hoxb4 locus based on noncoding conservation.  These and
other results demonstrated that deep comparisons are an efficient tool for enhancer
prediction, but genome-wide application was not possible at the time since none of these
vertebrate genome sequences were available.
A more recent study systematically exploited the remarkable potential of such distant
vertebrate sequence comparisons to identify gene enhancers at the scale of larger
genomic intervals [46].  In this work, the gene-sparse regions surrounding the human
DACH locus were scanned for sequences that are not only highly conserved among
mammals, but also had considerable sequence conservation in Xenopus as well as in
pufferfish.  Using an in vivo enhancer assay, these extremely conserved regions were
found to be highly enriched for enhancers that drive tissue-specific gene transcription
during embryogenesis.  In fact, many of the conserved elements that are currently being
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tested in a large-scale transgenic in vivo screen in our laboratory (see section 4.3) were
identified using human-fish conservation.
There are, however, several important limitations to distant comparative approaches.
First, their high specificity is accompanied by moderate sensitivity.  Depending on the
alignment method, the comparative strategy, and the stringency of the applied  filters,
previously reported numbers of conserved non-coding elements identified by human-fish
comparisons vary between 1,400 [47] and 5,700 [48].  Compared to estimates of the total
number of protein-coding genes in the human genome [49], this is up to an order of
magnitude lower, suggesting that many regulatory regions are missed by such distant
comparisons.  Second, to aggravate this problem, many elements with such extremely
deep conservation occur in clusters around genes implicated in transcriptional regulation
and development (trans-dev genes).  For example, 85% of the 1,400 human-fish CNSs
described by Woolfe et al. [47] are found in clusters of five or more elements.  In total,
only 165 distinct clusters were identified and 93% of these clusters are associated with
trans-dev genes.  In contrast, the majority of genes with other functions are not associated
with any deeply conserved elements, despite modular regulation of gene expression in
time and space.  Third, extremely distant comparisons are expected to identify
predominantly regulatory elements that are involved in molecular, developmental or
physiological mechanisms that exist in both species under consideration, thereby
explaining why they are anciently conserved.  Human-fish comparisons would therefore,
e.g. be of limited utility for studies of enhancers that are involved in mammalian-specific
developmental processes.  As an example, we performed comparative analysis
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retrospectively on a subset of heart-specific cis-regulatory sequences originally identified
through functional studies.  These elements drive gene expression in the anterior heart
field, a transient developmental structure, and heart regions derived from it [50].  The
vast majority lacked conservation outside of mammals, which may be partially due to
differences in heart development between mammals and non-mammalian vertebrates
(Fig. 1B).
Fig. 1 – Trade offs in comparative genomics of noncoding DNA based on different
phylogenetic distances.  A) With simple definitions of CNSs, conservation depth can be
used to calibrate specificity vs. sensitivity in comparative enhancer prediction.  Closer
sequence comparisons such as human-mouse provide a significant amount of noncoding
conservation which provides strong sensitivity to identify known putative function, but at
the cost of poor specificities.  In contrast, human-fish comparison yields relatively little
noncoding conservation and hence poor sensitivity to identify putative function, but with
strong specificities for those conserved elements it does identify.  B) Known heart
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enhancers lack deep sequence conservation.  In this illustrative example, retrospective
comparative analysis of twelve known heart-specific cis-regulatory elements in eleven
vertebrate genomes reveals limited sensitivity of deep comparisons for detecting
mammalian heart-specific enhancers (% identity refers to mouse as the base genome).
Most of these elements are only minimally conserved beyond mammals and would have
been missed by human-fish comparisons.  These data indicate that biological context is
an important factor for comparative-based approaches, though on occasion heart
enhancers are anciently conserved to fish.  For detailed description and experimental
characterization of these elements, see references 13,15,18,51-57.
3.2.2 Extreme Conservation within Mammals
If conventional comparative criteria such as 70% identity over at least 100bp are used,
human-rodent comparisons are of limited use for identification of enhancer elements.
This is due to the fact that these two species share a relatively short divergence time since
their last common ancestor which results in their high overall similarity even in non-
functional genome regions.  This results in the identification of an excess of elements as
illustrated by the observation that ~40% of the human and mouse genome are alignable,
yet only ~5% of the human genome are estimated to be under purifying selection [43].  In
consequence, using human-mouse comparisons with relatively relaxed percent identity
parameters for enhancer prediction is very sensitive, but results in a false-positive rate
that is too high to be useful for most applications [58,59].
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While an obvious solution is to seek more distant species for human genome comparison,
this problem can be partially overcome by using more stringent conservation criteria in
human-rodent comparisons alone.  Human-rodent “ultraconserved” elements are one such
class of extremely conserved human-rodent sequences and are defined as sequences of
200bp or more that are 100% identical between human, mouse and rat [60].  Thus, these
sequences are at the extreme end of the conserved human-mouse continuum which is
exemplified by there only being approximately 250 of such elements that do not overlap
with protein-coding sequences in our genome.  The function of these elements has not
been exhaustively explored, but studies of single ultraconserved elements [46,61] as well
as their genomic localization in clusters near key developmental genes [62] suggest that
many of them may be long-range modulators of gene transcription.
While ultraconserved elements are highly likely to be enhancers or other functional
elements, their value for large-scale prediction of enhancers is limited because they
represent only a relatively small subset of the functionally conserved sequences in the
human genome.  Their low total number indicates a poor sensitivity, suggesting that
many or most functional elements will be missed if ultraconservation alone is used to
screen a genomic interval of interest.  Moreover, because of the extreme conservation
criteria of ultraconserved elements, most of them coincide with regions that are also
conserved between human and fish.  However, it has recently been suggested that
statistically more rigorous methods than the original concept of ultraconservation might
provide a way to extract larger populations with ultra-like constraints from human-rodent
comparisons, increasing the sensitivity while maintaining the specificity associated with
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ultraconserved elements [48] (see section 4.1.2).  Computational tools to exploit this
concept are becoming increasingly available [48,63,64].
3.2.3 Comparison of Close Species: Primate Phylogenetic Shadowing
For studying regulatory elements related to aspects of biology that are specific to humans
or primates, but do not exist in more distant species such as rodents, distant comparisons
will only be useful in cases where previously existing regulatory features have assumed a
new function in the primate lineage.  However, distant comparisons will miss elements
that have evolved more recently and are possibly specific to the primate phylogenetic
branch.  On the other hand, comparison with other primates does not yield useful results
when conventional sequence comparison is performed due to the relatively short period
since the last common ancestor in the primate branch, e.g. ~25 million years for humans
and Old World monkeys [65].  This is exemplified to a severe degree in comparisons of
human and chimpanzee, which separated from their common ancestor ~7 million years
ago.  Between these two genomes ~99% of all nucleotides are conserved [66], rendering
conventional comparative approaches useless because virtually all regions of the genome
appear highly similar.  This problem can be overcome using a “phylogenetic shadowing”
approach [67].  In this method, the sequences of multiple, evolutionary close species such
as humans, apes and monkeys are aligned.  This depth of several species provides the
nucleotide diversity that would otherwise be achieved through more distant pair-wise
comparisons such as human-mouse.  Moreover, this approach incorporates a molecular
phylogenetic model to consider the phylogenetic relationships among the different
species that are compared such that changes that occurred in a closely-related species are
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given more power than those in a more distantly-related species.  Phylogenetic
shadowing requires aligned sequences from multiple closely related species and has
therefore so far only been used in the context of studies focusing on particular loci of
interest [67,68].  However, this method will likely become increasingly used for the
identification of primate-specific regulatory elements as more and more primate genomes
become available [69].
4.  Tools and Resources for Comparative Genomics
A number of tools are available to identify conserved noncoding elements in genome
sequences.  In this section, we will provide an overview of computational approaches and
web-based resources to interrogate and browse the human genome for such elements and
retrieve their sequences for experimental studies.  We also discuss approaches for
experimental characterization of developmental enhancers and describe the Vista
Enhancer Browser as a public database of experimentally validated enhancers.  Relevant
web addresses and references describing each of the listed resources are provided in
table 1.
4.1 Identification of Candidate Regions at a Genomic Scale
Identification of conserved elements by comparison of genomes from different species is
generally a two-step process.  First, homologous regions of two or more different
genomes are aligned at the nucleotide level, so that for each nucleotide position in the
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reference genome a best fit with the nucleotide at the respective position in the other
genome(s) is determined.  Second, based on this alignment, the different genomes are
compared at the nucleotide level and statistical methods are used to identify regions
where the sequence is more constrained (i.e. similar between the different organisms)
than what would be expected for neutrally evolving DNA.
4.1.1 Aligning Genome Sequences
For the alignment step, a range of whole genome methods has been developed and
several relevant programs are listed in table 1.  These generally fall into two categories:
local and global alignment approaches.  Local methods compare relatively short intervals
of genomic sequences with each other and return the best match between two genomes
for each sub-region.  However, because they do not take into account the region
surrounding these matches, they can result in false hits, e.g. returning a paralogous
sequence instead of the true ortholog.  In contrast, global methods align entire syntenic
regions and are less prone to return false-positive matches, but fail to recognize
homologous regions that have been locally rearranged by translocations of inversions.
Finally, “glocal” alignment [70] is a global alignment strategy that allows for local
rearrangements, thereby eliminating some of the problems associated with local-only or
global-only alignments.
While all three types of alignments have been successfully used for comparative
identification of functional elements, it is important to keep in mind that they will often
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return slightly different results for a particular genomics region of interest.  Thus, trial
and error approaches are appropriate to maximize the likelihood of biological discovery.
Identification of
conserved
elements
Available at URL
Based on
alignment
Display/Download
Percent identity plot
(PiP) [71,72]
Vista Genome
Browser [73]
http://pipeline.lbl.gov
SLAGAN
(pair-wise,
glocal*) [74]
Percent identity curves; display and
download of elements with adjustable
threshold identity percentage
Dcode ECR
Browser [75]
http://ecrbrowser.dcode.org
BLASTZ
(pair-wise,
local) [76]
Percent identity plots or curves; display
and download of elements with adjustable
threshold identity percentage
PhastCons [64]
UCSC Genome
Browser
[77,78]
http://genome.ucsc.edu
MULTIZ
(multiple,
local) [79]
UCSC genome browser „Most
Conserved“ track; download of elements
with adjustable constraint threshold
Gumby [48]
Vista Genome
Browser [73]
http://pipeline.lbl.gov
SLAGAN
(pair-wise,
glocal*) [74]
“RankVista” p-value bar plots; display
and download of elements with adjustable
threshold p-value
Vista Enhancer
Browser
http://enhancer.lbl.gov
MLAGAN
(multiple,
global) [70]
Browsable list of human-mouse-rat CNSs;
direct link to developmental enhancer
assay results where available
Tab. 1: Selected interactive genome browsing tools for the identification of vertebrate CNSs.
* “glocal” = global alignments allowing local rearrangements.
4.1.2 Scoring Conservation in Aligned Genome Sequences
For defining highly conserved elements in aligned genomes, there is also a range of
computational tools available.  We focus here on a small subset of such tools that is of
particular relevance for the identification of candidate enhancer sequences in the human
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genome by biomedical investigators (Fig. 2).  The most straightforward way to identify
highly constrained elements in genome alignments are pair-wise percent identity plots.
When using local alignment methods such as BLASTZ [76], the length and percent
identity of each aligned segment can be directly converted into a sequence plot [71] (Fig.
2A).  Alternatively, for two globally aligned sequences, a sliding window of user-defined
size (e.g. 100bp) is moved along the alignment and returns for each nucleotide position
the percentage of identity within the window [72] (Fig. 2B).  CNSs are in both cases
defined by a user-specified threshold, e.g. as regions exceeding 70% identity over at least
80bp.
Percent identity plots have been widely used because the concept is simple and readily
implemented, but they have several important limitations.  For example, they do not
allow direct multi-species comparisons, but rather multiple species can be indirectly
considered by aligning the pair-wise alignments to the same reference genome.
Moreover, they do not take into account the evolutionary distance between the species
that are being compared.  When using the same threshold (e.g. 70% identity, ≥100bp), the
choice of the species being compared can be used to roughly calibrate sensitivity versus
specificity (Fig. 1A).  For instance, CNSs identified by comparison of distant species
such as human-fish are highly enriched in functional enhancers [46].  However, the
relatively small number of such elements detected by this strategy indicates that it fails to
capture many functional sequences (see section 3.2.1).  In contrast, comparison of close
species such as human-mouse identifies hundreds of thousands of elements and is thus
more sensitive, but suffers from a high false-positive rate when such elements are tested
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for their tissue-specific enhancer activity in functional assays [58].  The problem of low
specificity in percent-identity types of comparisons between close species can be partially
alleviated by using more stringent threshold parameters.  For example, human-mouse-rat
“ultra”-conservation of 100% for ≥200bp [60] is similarly successful for enhancer
identification as deep human-fish conservation (AV, LAP, unpublished observations), but
is even less sensitive by an order of magnitude (see section 3.2.2).
Recently a new generation of advanced, mathematically and statistically rigorous tools
have become available that allow direct multi-species (n-way) comparisons while also
considering phylogenetic branch length and local neutral background substitution rates
[48,64].  Importantly, these methods do not require a single pre-specified evolutionary
distance [64] (Fig. 2C) and provide high specificity even in pair-wise comparisons of
relatively close species such as human and mouse [48] (Fig 2B).  Moreover, they use
statistical tests to assign quantitative scores to elements, allowing a user to rank all
elements within a given genomic interval according to the significance of their constraint.
We have started to explore the relative value of these different comparative methods for
prediction of tissue-specific enhancers by testing elements predicted by different methods
in a transgenic reporter assay (see below), where we find that these more advanced
comparative tools are indeed superior to simple percent identity plots in their ability to
predict functional enhancers.
In order to browse the human or other vertebrate genomes for the presence of elements
identified using the different methods described above, a variety of public resources is
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available online.  We provide a list of such sites in table 1, limiting our selection to those
resources that provide pre-aligned sequences and elements identified by the methods
described above.
Fig. 2 – Sequence display of the same human genome region by various tools for
comparative analysis.  A 15kb region comprising two exons of the GTP-binding protein
PTD004 is shown (chr2:174,805,000-174,820,000; hg17).  A) Percent identity plots as
displayed in the Dcode ECR browser.  B) Percent identity tracks and RankVista tracks in
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the Vista Genome Browser.  RankVista tracks are based on p-values of conserved
elements determined by the Gumby algorithm.  C) Conservation and PhastCons (“Most
Conserved”) tracks in the UCSC genome browser.  D) Experimental results for two CNSs
in the Vista Enhancer Browser.  See table 1 for relevant references.
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4.2 Experimental Validation of cis-Regulatory Elements
An array of experimental approaches is available to assess the potential for putative
regulatory elements to influence the expression of genes.  These include in vitro methods
for determination of consensus binding sites of specific transcription factors, evaluation
of potential accessibility of putative TFBSs by DNase I hypersensitivity assays,
electrophoretic mobility shift assays, and chromatin immunoprecipitation assays to
determine the binding sites of a specific transcription factor within the genome.  While
this field has experienced considerable progress in the past, all of these methods, even
when used in combination, are generally insufficient to successfully predict the location
of a particular enhancer element or its tissue-specificity in an animal, prompting the need
to validate and characterize putative enhancers in suitable in vivo assays.
Methods for in vivo testing of enhancer activities have been described for several
vertebrate model organisms, including zebrafish and Xenopus [40,47].  In this article we
will, however, focus on experimental approaches employing the mouse for determining
the in vivo activity of candidate human enhancer sequences.  Due to their shared
phylogeny as mammals, the mouse is a suitable model for many aspects of human
development, physiology, and disease.  Importantly, mice are among the mammalian
model organisms for which transgenic techniques have been available for many years,
enabling the easy and efficient introduction of reporter constructs into the genome.
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In order to study the in vivo properties of human enhancers, and in particular their ability
to drive tissue-specific expression during embryonic development, we have recently set
up a pipeline for testing of putative enhancers in transgenic mice (Fig. 3).  We identify
candidate elements by comparative criteria, such as human-fish comparison [46,80] or
“ultra”-conservation between humans and rodents [60,61] (Fig. 2D).  Then we assess the
potential of such candidate regulatory regions experimentally in a transgenic mouse
enhancer assay [81,82].  Candidate regions are PCR-amplified from human genomic
DNA and cloned into a reporter vector in which they are fused to a minimal heat shock
protein 68 promoter and a beta-galactosidase reporter gene.  On its own, this vector does
not drive beta-galactosidase gene expression in mammalian embryonic tissues [81,82],
but when fused to a DNA fragment with gene enhancer properties, spatial and temporal
patterns of expression can be robustly and reproducibly characterized.  This construct is
injected into one of the two pronuclei of fertilized mouse oocytes, where it integrates into
the genomic DNA at a random position, usually in multiple copies.  The oocytes are then
implanted into pseudo-pregnant females, embryos are harvested at embryonic day 11.5
and stained for beta-galactosidase activity using X-Gal as a chromogenic substrate.
We chose this particular stage of development for analysis for several reasons.  (1) Many
human-fugu and ultra-conserved elements reside near genes that are expressed in early
development [60,62].  (2) Whole embryo staining at this time-point enables the global
identification of enhancer expression features without bias for particular tissues.  (3) This
is a key time-point during organogenesis at which most structures are present.  Our
preliminary studies of ~150 human-fugu elements indicate that this time-point is able to
-30-
catch enhancer activities for >40% of the fragments tested, in contrast to moderately
conserved human-rodent fragments where less than 5% of fragments behave as enhancers
at this time-point [58].  Due to position effects that can alter in vivo enhancer
characteristics as a result of the transgene integration site, we generate >5 independent
transgenic animals per injection and require that at least 3 of these independent founders
for each construct show reproducible spatial expression characteristics before assigning a
conserved element an associated regulatory activity.
Compared with the generation of traditional BAC or YAC transgenic lines, use of this
transient transgenic method results in a dramatically increased throughput that allows us
to currently test 500 elements per year.  This assay has previously been used in numerous
gene-centric studies, where its reproducibility and high spatiotemporal resolution has
provided valuable insights into the in vivo activities of single elements of interest.  This
increase in throughput allows application of this method at a genomic scale, without
requiring guidance by their neighboring genes.
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Fig. 3 - Experimental design.  Identification (example alignment displayed as Vista
track), cloning and transgenic testing of candidate enhancer sequences.
4.3 Enhancer Browser: Large-Scale Data Set of in vivo-Validated Enhancers
In order to make the results of our enhancer screen available to the scientific community,
we have established a public database, the Vista Enhancer Browser, which is available at
http://enhancer.lbl.gov (Fig. 4A).  This browser houses two principal kinds of data: 1)
experimental results from our in vivo screen and 2) a large collection of vertebrate
noncoding sequences that are evolutionary conserved at varying distances.
4.3.1 Experimental Data
The experimental results of our transgenic in vivo screen constitute the core data set of
the enhancer browser.  Each tested fragment has an associated dataset (Fig. 4C)
consisting of sequence-related information and the experimental results.  Sequence-
related information includes the genomic coordinates, names of neighboring genes, PCR
primers used to amplify the element from human genomic DNA, and an overview of the
conservation in various species.  The results of the transgenic enhancer assay are
provided both in the form of pictures of embryos with representative reporter gene
activity and in anatomical annotation format.  To be considered positive in our assay, an
element has to drive reporter gene expression in the same anatomical structure in at least
three independent transgenic embryos.  Elements in which no such reproducibility is
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observed, although a sufficient number of transgenic embryos was generated (generally at
least five transgenics confirmed by PCR genotyping) are reported as negative and no
pictures of the embryos are shown.  For positive elements, a selection of representative
embryos is displayed.  The images for each embryo can be retrieved as high-resolution
files and are often supplemented by images at higher magnification or from more
informative angles than the standard sagittal overview of the whole-mount specimen.
In order to enable searches of our data as well as bulk downloads, we annotate the tissue
specificity of each positive enhancer identified using a list of anatomical terms that is
largely consistent with existing standardized nomenclature [83].  We thus provide the
ratio of LacZ-positive embryos versus all transgenic embryos separately for each
structure (Fig. 4C).  A text-based query function is available on the front page of the
enhancer browser.  Using this feature, the database can also be searched by genomic
coordinates, gene names, accession number and Entrez Gene IDs.  An additional
comprehensive search tool is available for more advanced queries of the database.  This
includes searches for enhancers that are specific for a particular anatomical structure of
interest (Fig. 4B) and/or restriction of the search to elements of a user-defined
conservation depth (e.g. human-frog or human-fugu).
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Figure 4 – Retrieving Data from the Vista Enhancer Browser.  A) Entry page with
basic query function.  B) Advanced search page with query form for experimental data.
The results of a search for enhancers with hindbrain expression are shown.  Each row in
the results table corresponds to one experimental data set.  A representative embryo is
shown for the first five data sets.  C) Full data set display mode.  Top: Coordinates of
element, neighboring genes, anatomical description of expression patterns and pictures of
representative embryos.  Note that each embryo is an independent transgenic F0 animal.
Overview pictures and magnified views of expression sites are provided; all images can
be downloaded at high resolution.  Bottom: Sequence of element, PCR primers used for
cloning and conservation profile linked to UCSC genome browser.
4.3.2 Computational Data Set
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In addition to the experimental and external data, the enhancer browser also provides a
genome-wide computationally generated set of more than 145,000 highly conserved
elements for which no experimental data from the transgenic assay is available.  These
elements were identified using Gumby/RankVista with globally aligned human-mouse-
rat sequences [48].  Only elements with a p-value <= 0.001 that do not overlap known
mRNAs or spliced expressed sequence tags were considered for this data set.  All of these
elements were then checked for their conservation in chicken, frog, zebrafish and fugu to
determine the conservation depth which is provided at the website.  While we plan to test
some subsets of this large collection of highly conserved elements in the future, the major
purpose of this collection is to provide users with an easily accessible list of candidate
regions for genomic intervals of interest for analysis in complementary computational
and experimental approaches.  Similar datasets can be obtained from other resources
listed in table 1.
The computational data set is searchable using the same query functions as the
experimental data set and the results of such searches are returned in the same list format.
In particular, the search function can be used to locate all elements of a user-defined
conservation depth (e.g. human-fish) in a particular genomic interval.  By definition no
experimental data is available for elements that are part of the computational data set,
therefore following the link for a particular element will open the UCSC browser view
with aligned Vista conservation plots for the respective coordinates.
5.  Conclusions and Perspectives
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While gene regulation studies were possible in the pre-genome era, they were
exceedingly expensive and time-consuming.  Distant enhancers flanking a gene of
interest were usually painstakingly identified through historic deletion series in transgenic
animals.  These experiments occurred sequentially in a largely trial and error fashion until
the minimum sequence necessary to drive a given expression pattern was identified.
Retrospective comparative analysis reveals that many of these functionally identified
fragments strongly overlap with highly conserved regions of the human genome.  For
example, the distal liver-specific enhancer of APOE, a protein that impacts cholesterol
metabolism, cardiovascular and Alzheimer’s disease, was originally identified through
such testing of many overlapping gene fragments in transgenic mice [6,7], but
retrospective comparative analysis revealed that simple percent identity plot human-
mouse comparisons would have readily identified this hepatic control region [84].  As is
the case for numerous regulatory elements, had comparative data been available prior to
beginning these experiments, hypotheses based on sequences under evolutionary
constraint could have directly guided these studies from their inception.
Today, with this background experience, we are privileged to begin studies with
computational sequence analysis followed by functional investigations.  Such an
approach can occur on a gene-by-gene basis or at a whole genome level of analysis.  As a
caveat, we should emphasize that comparative-based approaches are not without
limitations.  Some enhancers will lack conservation or may be missed by current
computational tools, as illustrated in this article by the relatively weak conservation of
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many experimentally identified enhancers involved in heart development (Fig. 1B).
While the thought of more vertebrate species genomic sequences is a daunting data
management task, their availability will without doubt further improve our ability to
know which species to compare to address which biological question and allow
additional flexibility in the choice of organisms used in multi-species analyses.
Importantly, the possibility of deep alignments across a wide range of vertebrate taxa will
also increasingly allow us to address the relation between noncoding sequences and
phenotypic diversity.  One paradigmatic example to this end was the analysis of the
aforementioned Hoxc8 early enhancer in a panel of mammals that suggested that
evolution of this enhancer contributed to the differences in axial morphology
distinguishing baleen whales from other mammals [85].  While this study in the pre-
genomic era relied on targeted sequencing of this regulatory element in a large number of
species in the mammalian clade, the ever-growing number of available vertebrate
sequences will increasingly allow for similar such studies at genomic scale.
The moderate-scale experimental testing of candidate enhancers through transgenic
approaches such as that described here are expected to provide larger training sets for
improved computational predictions of what activities conserved sequences are likely to
contain.  The first level of annotation in this area is occurring on the most highly (human-
rodent "ultra") and deepest (human-fish) conserved elements in the human genome.
These classes of conserved noncoding elements are enriched near genes active in early
development and this is not universally applicable for all types of known enhancers.
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Rather, they will serve to demonstrate how one can go from comparative sequence data
to their functional testing to using the resulting dataset to computationally predict
additional such enhancer elements in the larger human genome.  It is anticipated that
through such an iterative process we will learn vital clues as to developmental enhancer
function and that this knowledge will translate into a deeper understanding of the
regulation of both developmental and non-developmental genes in vertebrates.
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